Non-Small Cell Lung Cancer (NSCLC) Symptoms: Early Detection and Diagnostic Insights
At a Glance
- Sample Required: Blood or tissue biopsy (for genetic testing)
- Fasting Rules: No fasting required for blood draw; biopsy may require specific prep
- Turnaround Time (TAT): 7–14 business days for genetic panels
- Base Cost: [Insert Current 2026 Price]
Understanding Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all cases. In India, it represents a significant oncological burden, with over 70,000 new cases diagnosed annually. NSCLC is often termed a "silent disease" because early-stage symptoms are subtle and easily mistaken for common respiratory ailments. Early detection dramatically improves survival rates, making awareness of warning signs critical.
Early Warning Signs You Shouldn't Ignore
While NSCLC may not produce symptoms in its earliest stages, certain persistent changes warrant medical attention:
- Persistent Cough: A cough lasting more than three weeks, especially in non-smokers, should be evaluated.
- Change in Cough Pattern: A chronic cough that becomes deeper, produces more mucus, or is tinged with blood.
- Chest Pain: Discomfort that worsens with deep breathing, coughing, or laughing.
- Shortness of Breath: Breathlessness after minimal exertion or at rest.
- Wheezing: A whistling sound during breathing, indicating possible airway obstruction.
- Hoarseness: Unexplained voice changes due to tumor pressure on vocal cords.
Advanced Symptoms as the Disease Progresses
As NSCLC advances, systemic symptoms may emerge:
- Unexplained Weight Loss: Loss of more than 5% of body weight within 6–12 months without dieting.
- Loss of Appetite: Persistent lack of interest in food.
- Fatigue: Debilitating tiredness that interferes with daily activities.
- Recurrent Lung Infections: Frequent bronchitis or pneumonia episodes.
Symptom Timeline: When to Seek Medical Attention
| Symptom | Duration | Action |
|---|---|---|
| Persistent cough | >3 weeks | Consult physician |
| Cough with blood | Any duration | Immediate medical evaluation |
| Shortness of breath | Progressive | Schedule pulmonary assessment |
| Unexplained weight loss | >5% in 6 months | Comprehensive check-up |
Diagnostic Approach at DNA Labs India
If you experience any of the above symptoms, your physician may recommend imaging (CT scan, PET-CT) and biopsy. At DNA Labs India, we offer advanced molecular diagnostics to guide treatment decisions:
- Next-Generation Sequencing (NGS): Comprehensive genomic profiling to identify actionable mutations (EGFR, ALK, ROS1, BRAF, etc.).
- Whole Exome Sequencing (WES): For hereditary cancer risk assessment and rare mutation detection.
- Liquid Biopsy: Non-invasive detection of circulating tumor DNA (ctDNA) for monitoring and resistance mutations.
Our laboratory is ISO 9001 certified, ensuring high-quality standards in every test.
Genetic Testing and Personalized Treatment
NSCLC is driven by specific genetic alterations. Identifying these through NGS or WES enables targeted therapies, which have significantly improved outcomes. For example, EGFR mutations are present in ~30% of Indian NSCLC patients, making tyrosine kinase inhibitors (TKIs) highly effective. Genetic testing also helps identify hereditary syndromes, guiding family screening.
Take Control of Your Health
If you have risk factors such as smoking history, occupational exposure, or family history of lung cancer, discuss screening options with your doctor. Early detection saves lives. DNA Labs India offers comprehensive genetic panels to support your journey.
Written by: Dr. Ananya Sharma, MBBS, MD (Internal Medicine)
Medically Reviewed by: Dr. Rajesh Kumar, PhD (Medical Genetics)
Last Updated: February 2026